Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients
Authors:
- Johannes BrachmannJBJohannes Brachmann
- Carlos A. MorilloCMCarlos A. Morillo
- Tommaso SannaTSTommaso Sanna
- Vincenzo Di LazzaroVLVincenzo Di Lazzaro
- Hans-Christoph DienerHDHans-Christoph Diener
- Richard A. BernsteinRBRichard A. Bernstein
- Marylin RymerMRMarylin Rymer
- Paul D. ZieglerPZPaul D. Ziegler
- Shufeng LiuSLShufeng Liu
- Rod S. PassmanRPRod S. Passman
- 1 January 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 9 (1) , e003333
Abstract
Background—: Atrial fibrillation (AF) can be a cause of previously diagnosed cryptogenic stroke. However, AF can be paroxysmal and asymptomatic, thereby making detection with routine ECG methods difficult. Oral anticoagulation is highly effective in reducing recurrent stroke in patients with AF, but its initiation is dependent on the detection of AF. Cryptogenic Stroke and Underlying Atrial Fibrillation (CRYSTAL AF) is the first randomized study to report the detection of AF in cryptogenic stroke patients using continuous long-term monitoring via insertable cardiac monitors (ICM). Methods and Results—: Patients with prior cryptogenic stroke were randomized to control (n=220) or ICM (n=221) and followed for ≤36 months. Cumulative AF detection rates in the ICM arm increased progressively during this period (3.7%, 8.9%, 12.4%, and 30.0% at 1, 6, 12, and 36 months, respectively), but remained low in the control arm (3.0% at 36 months). This resulted in oral anticoagulation prescription in 94.7% of ICM patients with AF detected at 6 months, 96.6% at 12 months, and 90.5% at 36 months. Among ICM patients with AF detected, the median time to AF detection was 8.4 months, 81.0% of first AF episodes were asymptomatic, and 94.9% had at least 1 day with >6 minutes of AF. Conclusions—: Three-year monitoring by ICM in cryptogenic stroke patients demonstrated a significantly higher AF detection rate compared with routine care. Given the frequency of asymptomatic first episodes and the long median time to detection, these findings highlight the limitations of using traditional AF detection methods. The majority of patients with AF were prescribed oral anticoagulation therapy. Clinical Trial Registration—: Clinicaltrials.gov ; Unique identifier: NCT00924638.Keywords
This publication has 37 references indexed in Scilit:
- Cryptogenic stroke: Is silent atrial fibrillation the culprit?Heart Rhythm, 2015
- Cryptogenic Stroke and Underlying Atrial FibrillationNew England Journal of Medicine, 2014
- Detection of Atrial Fibrillation After Stroke and the Risk of Recurrent StrokeJournal of Stroke and Cerebrovascular Diseases, 2012
- Detection of Atrial Fibrillation With Concurrent Holter Monitoring and Continuous Cardiac Telemetry Following Ischemic Stroke and Transient Ischemic AttackJournal of Stroke and Cerebrovascular Diseases, 2012
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Intermittent Atrial Fibrillation May Account for a Large Proportion of Otherwise Cryptogenic Stroke: A Study of 30-Day Cardiac Event MonitorsJournal of Stroke and Cerebrovascular Diseases, 2009
- Comparison of continuous versus intermittent monitoring of atrial arrhythmiasHeart Rhythm, 2006
- Relationship between atrial tachyarrhythmias and symptomsHeart Rhythm, 2005
- Differences in Vascular Risk Factors Between Etiological Subtypes of Ischemic StrokeStroke, 2003
- Infarcts of undetermined cause: The NINCDS stroke data bankAnnals of Neurology, 1989